Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...

Patients with MASLD had nearly twice the all-cause mortality rate as the general population, suggesting the need for multidisciplinary care to reduce excess mortality, researchers said.

Survival depends on different factors. No one can tell you exactly how long you will live. Doctors usually work out the outlook for a certain disease by looking at large groups of people. Primary ...

Younger age, substance use, and HCC may be risk factors for repeat HCV viremia in patients who achieve SVR following DAA therapy.

The "Hepatoblastoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.The Global Hepatoblastoma ...

Japanese researchers sought to build upon prior studies demonstrating the feasibility of liver resection in geriatric hepatocellular carcinoma patients, particularly in those undergoing major ...

The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.